International Stem Cell Corporation a California-based biotechnology company developing novel stem cell based therapies, announced today the pricing of a public offering of 20,000,000 units, each unit consisting of one share of our common stock and one Series A Warrant to purchase one share of our common stock at an exercise price of $0.15 per ... (more)
http://technews.tmcnet.com/news/2013/07/19/7288212.htm
http://technews.tmcnet.com/news/2013/07/19/7288212.htm
No comments:
Post a Comment